Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years' Experience in the UK.
Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years' Experience in the UK.
复制标题
DOI:
10.1210/jendso/bvab086
复制
发表时间:
2021-08-01
影响因子:
4.1
通讯作者:
Achermann JC
中科院分区:
文献类型:
--
作者:
Buonocore F;Maharaj A;Qamar Y;Koehler K;Suntharalingham JP;Chan LF;Ferraz-de-Souza B;Hughes CR;Lin L;Prasad R;Allgrove J;Andrews ET;Buchanan CR;Cheetham TD;Crowne EC;Davies JH;Gregory JW;Hindmarsh PC;Hulse T;Krone NP;Shah P;Shaikh MG;Roberts C;Clayton PE;Dattani MT;Thomas NS;Huebner A;Clark AJ;Metherell LA;Achermann JC
Although primary adrenal insufficiency (PAI) in children and young people is often due to congenital adrenal hyperplasia (CAH) or autoimmunity, other genetic causes occur. The relative prevalence of these conditions is poorly understood. We investigated genetic causes of PAI in children and young people over a 25 year period. Unpublished and published data were reviewed for 155 young people in the United Kingdom who underwent genetic analysis for PAI of unknown etiology in three major research centers between 1993 and 2018. We pre-excluded those with CAH, autoimmune, or metabolic causes. We obtained additional data from NR0B1 (DAX-1) clinical testing centers. Genetic analysis involved a candidate gene approach (1993 onward) or next generation sequencing (NGS; targeted panels, exomes) (2013-2018). A genetic diagnosis was reached in 103/155 (66.5%) individuals. In 5 children the adrenal insufficiency resolved and no genetic cause was found. Pathogenic variants occurred in 11 genes: MC2R (adrenocorticotropin receptor; 30/155, 19.4%), NR0B1 (DAX-1; 7.7%), CYP11A1 (7.7%), AAAS (7.1%), NNT (6.5%), MRAP (4.5%), TXNRD2 (4.5%), STAR (3.9%), SAMD9 (3.2%), CDKN1C (1.3%), and NR5A1/steroidogenic factor-1 (SF-1; 0.6%). Additionally, 51 boys had NR0B1 variants identified through clinical testing. Although age at presentation, treatment, ancestral background, and birthweight can provide diagnostic clues, genetic testing was often needed to define the cause. PAI in children and young people often has a genetic basis. Establishing the specific etiology can influence management of this lifelong condition. NGS approaches improve the diagnostic yield when many potential candidate genes are involved.
登录
查看更多内容
DOI:
10.1210/jc.2015-3250
发表时间:
2016-01
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
Guran T;Buonocore F;Saka N;Ozbek MN;Aycan Z;Bereket A;Bas F;Darcan S;Bideci A;Guven A;Demir K;Akinci A;Buyukinan M;Aydin BK;Turan S;Agladioglu SY;Atay Z;Abali ZY;Tarim O;Catli G;Yuksel B;Akcay T;Yildiz M;Ozen S;Doger E;Demirbilek H;Ucar A;Isik E;Ozhan B;Bolu S;Ozgen IT;Suntharalingham JP;Achermann JC
通讯作者:
Achermann JC
影响因子:
3.2
作者:
Chung TT;Chan LF;Metherell LA;Clark AJ
通讯作者:
Clark AJ
影响因子:
5.8
作者:
Bornstein, Stefan R.;Allolio, Bruno;Torpy, David J.
通讯作者:
Torpy, David J.
影响因子:
30.8
作者:
Arboleda VA;Lee H;Parnaik R;Fleming A;Banerjee A;Ferraz-de-Souza B;Délot EC;Rodriguez-Fernandez IA;Braslavsky D;Bergadá I;Dell'Angelica EC;Nelson SF;Martinez-Agosto JA;Achermann JC;Vilain E
通讯作者:
Vilain E
影响因子:
3.2
作者:
Chan LF;Metherell LA;Krude H;Ball C;O'Riordan SM;Costigan C;Lynch SA;Savage MO;Cavarzere P;Clark AJ
通讯作者:
Clark AJ